These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23039767)

  • 1. Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease.
    Valasani KR; Hu G; Chaney MO; Yan SS
    Chem Biol Drug Des; 2013 Feb; 81(2):238-49. PubMed ID: 23039767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
    Yao J; Du H; Yan S; Fang F; Wang C; Lue LF; Guo L; Chen D; Stern DM; Gunn Moore FJ; Xi Chen J; Arancio O; Yan SS
    J Neurosci; 2011 Feb; 31(6):2313-20. PubMed ID: 21307267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors.
    Valasani KR; Vangavaragu JR; Day VW; Yan SS
    J Chem Inf Model; 2014 Mar; 54(3):902-12. PubMed ID: 24555519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment.
    Hroch L; Benek O; Guest P; Aitken L; Soukup O; Janockova J; Musil K; Dohnal V; Dolezal R; Kuca K; Smith TK; Gunn-Moore F; Musilek K
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3675-8. PubMed ID: 27287370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
    Hroch L; Guest P; Benek O; Soukup O; Janockova J; Dolezal R; Kuca K; Aitken L; Smith TK; Gunn-Moore F; Zala D; Ramsay RR; Musilek K
    Bioorg Med Chem; 2017 Feb; 25(3):1143-1152. PubMed ID: 28082069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico-designed novel non-peptidic ABAD L
    Viswanath ANI; Kim T; Jung SY; Lim SM; Pae AN
    Chem Biol Drug Des; 2017 Dec; 90(6):1041-1055. PubMed ID: 28660722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.
    Valaasani KR; Sun Q; Hu G; Li J; Du F; Guo Y; Carlson EA; Gan X; Yan SS
    Curr Alzheimer Res; 2014 Feb; 11(2):128-36. PubMed ID: 24479630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease.
    Marques AT; Fernandes PA; Ramos MJ
    Mini Rev Med Chem; 2009 Jul; 9(8):1002-8. PubMed ID: 19601895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.
    Morsy A; Trippier PC
    J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.
    Lustbader JW; Cirilli M; Lin C; Xu HW; Takuma K; Wang N; Caspersen C; Chen X; Pollak S; Chaney M; Trinchese F; Liu S; Gunn-Moore F; Lue LF; Walker DG; Kuppusamy P; Zewier ZL; Arancio O; Stern D; Yan SS; Wu H
    Science; 2004 Apr; 304(5669):448-52. PubMed ID: 15087549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics.
    Kissinger CR; Rejto PA; Pelletier LA; Thomson JA; Showalter RE; Abreo MA; Agree CS; Margosiak S; Meng JJ; Aust RM; Vanderpool D; Li B; Tempczyk-Russell A; Villafranca JE
    J Mol Biol; 2004 Sep; 342(3):943-52. PubMed ID: 15342248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screening.
    Valasani KR; Chaney MO; Day VW; Shidu Yan S
    J Chem Inf Model; 2013 Aug; 53(8):2033-46. PubMed ID: 23777291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model.
    Zakaria A; Hamdi N; Abdel-Kader RM
    Mol Neurobiol; 2016 Mar; 53(2):1220-1228. PubMed ID: 25601181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease].
    Benek O; Musílek K; Kuca K
    Ceska Slov Farm; 2012 Aug; 61(4):144-9. PubMed ID: 23251955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD).
    Powell AJ; Read JA; Banfield MJ; Gunn-Moore F; Yan SD; Lustbader J; Stern AR; Stern DM; Brady RL
    J Mol Biol; 2000 Oct; 303(2):311-27. PubMed ID: 11023795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer's Disease.
    Aitken L; Baillie G; Pannifer A; Morrison A; Jones PS; Smith TK; McElroy SP; Gunn-Moore FJ
    SLAS Discov; 2017 Jul; 22(6):676-685. PubMed ID: 28314118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of small-molecule inhibitors of the Abeta-ABAD interaction.
    Xie Y; Deng S; Chen Z; Yan S; Landry DW
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4657-60. PubMed ID: 16781151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics.
    Vangavaragu JR; Valasani KR; Fang D; Williams TD; Yan SS
    J Alzheimers Dis; 2014; 42(1):333-44. PubMed ID: 24858403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.
    Takuma K; Yao J; Huang J; Xu H; Chen X; Luddy J; Trillat AC; Stern DM; Arancio O; Yan SS
    FASEB J; 2005 Apr; 19(6):597-8. PubMed ID: 15665036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalized Allopurinols Targeting Amyloid-Binding Alcohol Dehydrogenase Rescue Aβ-Induced Mitochondrial Dysfunction.
    Morsy A; Maddeboina K; Gao J; Wang H; Valdez J; Dow LF; Wang X; Trippier PC
    ACS Chem Neurosci; 2022 Jul; 13(14):2176-2190. PubMed ID: 35802826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.